Search results
CAR T-Cell therapy revolutionised landscape of cancer treatment: Doctors
Investing.com· 1 day agoNew Delhi, May 21 (IANS) A 42-year-old man from Bengaluru has successfully achieved "durable...
AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
Pharmaceutical Technology via Yahoo Finance· 21 hours agoEditorial content is independently produced and follows the highest standards of journalistic...
Earnings call: Adaptimmune outlines afami-cel launch and financials By Investing.com
Investing.com· 7 days agoAdaptimmune Therapeutics PLC (NASDAQ:ADAP), a biotechnology company specializing in T-cell therapy,...
Keeping CAR T Cells Sharp
The Scientist· 1 day agoResearchers have observed that certain types of CAR T cells are more effective at eradicating cancer. One especially advantageous quality is a...
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration...
Morningstar· 6 days agoBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular ...
ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple...
FOX 23 News Albany· 20 hours agoImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to ...
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
FOX 23 News Albany· 20 hours agoThe study is being conducted through a research partnership with Moffitt Cancer Center.
...IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF...
Morningstar· 5 days agoBreakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor IMDELLTRA Demonstrated Impressive 40% Objective Response Rate, 9.7 Month Median Duration of Response and ...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 6 days agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe CD19-directed chimeric antigen receptor (CAR) T cell therapy is indicated for patients who have...